Home / Resources (page 683)

Resources

RESOURCES

Generic Actoplus Met® Tablets and Generic Actos® Tablets

Mylan

Generic Actoplus Met® Tablets and Generic Actos® Tablets Mylan, Inc. announced that it has received final approval from FDA for its Abbreviated New Drug Application (ANDA) for Pioglitazone Tablets USP, 15 mg, 30 mg and 45 mg. Previously, the company also received final approval from the FDA for its ANDA …

Read More »

Faustman’s Type 1 Diabetes Cure Raises Debate

Dr. Denise Faustman’s announcement of the results of a small study of a handful of type 1 patients showing the regeneration of beta cells with the use of a TB vaccine that has been available for years is causing a controversy in the medical community…. If the findings do hold …

Read More »